日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Serial innovations by Asgard archaea shaped the DNA replication machinery of the early eukaryotic ancestor

阿斯加德古菌的一系列创新塑造了早期真核祖先的DNA复制机制。

期刊:Nature Ecology & Evolution
影响因子:14.5
doi:10.1038/s41559-025-02882-6
Feng, Yanlei; Ding, Jingjing; Lin, Youxiong; Cui, Danxi; Li, Kejing; Zheng, Daoqiong; Cai, Zongwei; Bell, Stephen D; Wu, Fabai
发表日期：2025
文献求助 收藏

Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical Trial

强化收缩压降低与肾脏和心血管结局：一项随机临床试验的二次分析

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.19604
Sun, Guozhe; Miao, Wei; Liu, Songyue; Yin, Yangzhi; Geng, Danxi; Ye, Ning; Xie, Ziyi; Zhang, Linlin; Zhou, Shiyu; Wang, Chang; Qiao, Lixia; Pei, Sitong; Ouyang, Nanxiang; Shi, Chuning; Guo, Xiaofan; Sun, Yingxian
发表日期：2025
文献求助 收藏

Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy

预测初始不可切除肝细胞癌患者的复发和无复发生存期：一种用于接受乐伐替尼、PD-1抑制剂和介入治疗的转化性肝切除术患者的新型列线图

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1602327
Xu, Cheng; Tang, Zhihong; Wei, Meng; Liu, Danxi; Pang, Qingqing; Huang, Baishan; Mo, Xinglin; Wu, Feixiang
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial

代谢综合征患者心血管疾病的强化血压管理策略：一项临床试验的事后分析

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.124.036820
Sun, Guozhe; Guo, Xiaofan; Li, Guangxiao; Zhang, Pengyu; Yin, Yangzhi; Qiao, Lixia; Ye, Ning; Wang, Chang; Liu, Songyue; Geng, Danxi; Miao, Wei; Xie, Ziyi; Yu, Yao; Li, Zhi; Jiang, Xiaoqiong; Tan, Xiangyu; Sun, Yingxian
心血管
心血管疾病
代谢综合征
代谢
发表日期：2025
文献求助 收藏

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors

乙型肝炎病毒术后再激活及其对接受介入治疗联合酪氨酸激酶抑制剂和免疫检查点抑制剂治疗的乙肝相关肝细胞癌患者生存率的影响

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2025.1598193
Xu, Shaowei; Pang, Qingqing; Wei, Meng; Liu, Danxi; Yuan, Du; Bai, Tao; Wang, Xiaobo; Tang, Zhihong; Wu, Feixiang
肿瘤
肿瘤免疫
信号转导
微生物学
细胞生物学
肝炎
免疫/内分泌
发表日期：2025
文献求助 收藏

Personalized insights into liver disease management: a text mining analysis of online consultation data

基于文本挖掘分析的在线咨询数据，为肝病管理提供个性化见解

期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2025.1467117
Xiang, Kun; Shi, Danxi
发表日期：2025
文献求助 收藏

Association of past obesity and BMI trajectories with cancer mortality: a prospective cohort study

既往肥胖及BMI变化轨迹与癌症死亡率的关联：一项前瞻性队列研究

期刊:Archives of Public Health
影响因子:3.2
doi:10.1186/s13690-025-01576-6
Zhang, Huan; Zhao, Junlong; Wang, Chenchen; Zhang, Jing; Zhu, Xiaojing; Li, Danxi; Han, Zheyi; Shang, Lei; Shi, Yongquan
肿瘤
肥胖
肿瘤免疫
代谢
发表日期：2025
文献求助 收藏

Hypertension Control in China: Translation from Clinical Trial to Real-World Application - Preliminary Outcomes

中国高血压控制：从临床试验到实际应用——初步结果

期刊:China CDC Weekly
影响因子:2.9
doi:10.46234/ccdcw2025.113
Sun, Guozhe; Peng, Hao; Liu, Songyue; Wang, Chang; Tan, Xiangyu; Fu, Jia; Dong, Wenlan; Liu, Fang; Guo, Xiaofan; Qiao, Lixia; Ouyang, Nanxiang; Miao, Wei; Geng, Danxi; Yin, Yangzhi; Xie, Ziyi; Zhang, Pengyu; Zhang, Caiyu; He, Chenhua; Wu, Jing; Sun, Yingxian
心血管
高血压
发表日期：2025
文献求助 收藏

Safety and efficacy of salvage surgery for unresectable hepatocellular carcinoma after conversion with triple therapy: a systematic review and meta-analysis of data from Chinese patients

三联化疗后不可切除肝细胞癌挽救性手术的安全性和有效性：一项来自中国患者的系统评价和荟萃分析

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-025-04122-4
Pang, Qingqing; Mo, Xingling; Tang, Zhihong; Wei, Meng; Liu, Danxi; Zhou, Zenghua; Huang, Baishan; Bai, Tao; Wang, Xiaobo; Wu, Feixiang
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Molecular features influencing clinical outcome of advanced HER2-positive gastric cancer receiving trastuzumab plus chemotherapy

影响接受曲妥珠单抗联合化疗的晚期HER2阳性胃癌患者临床疗效的分子特征

期刊:
影响因子:
doi:10.1080/07853890.2025.2581815
Lei, Yu; He, Danxi; Si, Jiqing; Yan, Junrong; Yuan, Minchi
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2025
文献求助 收藏